Acute respiratory distress syndrome: Difference between revisions

From IDWiki
(Imported from text file)
 
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations")
Line 54: Line 54:
* Other (5%)
* Other (5%)


== Clinical Presentation ==
== Clinical Manifestations ==


* Dyspnea and escalating ventilatory requirements following a known cause of ARDS
* Dyspnea and escalating ventilatory requirements following a known cause of ARDS

Revision as of 13:32, 19 July 2020

Summary

  • Lung damage that occurs within one week of an insult, with bilateral CXR opacities, not explain by other causes
  • Severity based on P:F ratio: severe <100, moderate 100-200, and mild 200-300
  • Lung protective ventilation reduces mortality
    • VT 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45

Definition

  • Syndrome of diffuse alveolar and interstitial edema
  • "Baby lung": small effective lung volume, because the dependent portions are filled with fluid

Berlin Definition (2012)

  • Syndrome, not disease, per European task force in 2012
  • Timing: within 1 week of a known insult
  • Origin of edema: not cardiac or hydrostatic edema
  • Chest imaging bilateral opacities not otherwise explained
  • Severity based on oxygenation
    • Mild: ratio of PaO2/FiO2 between 200-300 with PEEP over 5 cmH2O (27% mortality)
    • Moderate: ratio between 100 and 200 with PEEP over 5 cmH2O (32% mortality)
    • Severe: ratio below 100 with PEEP over 5 cmH2O (45% mortality)

Causes

  • Direct
    • Pneumonia
    • Aspiration
    • Inhalational injury
    • Pulmonary contusion
    • Near-drowning
  • Indirection
    • Sepsis
    • Major trauma
    • Multiple blood product transfusions
    • Pancreatitis
    • Shock
    • Drug overdose
    • Amniotic fluid embolism

Pathophysiology

  • Acute edema from neutrophil activation, with formation of hyaline membranes, and eventual fibrosis
  • Type I pneumocytes replaced with type II
  • Lungs become less compliant, due to a decrease in the available lung volume

Differential Diagnosis

  • ARDS (50%)
  • Pneumonia (25%)
  • Pulmonary edema (11%)
  • Invasive aspergillosis (6%)
  • Pulmonary embolism (3%)
  • Other (5%)

Clinical Manifestations

  • Dyspnea and escalating ventilatory requirements following a known cause of ARDS

Investigations

  • Chest x-ray showing bilateral infiltrates
  • Bronchoalveolar lavage (BAL)
    • Excludes the diagnosis if less than 5% neutrophils (can be over 80% in ARDS)
    • Suggestive if lavage to plasma protein ratio > 0.7 (less than 0.5 in hydrostatic edema)

Management

  • Lung-protective ventilation (see ARDS ventilation protocol)
    • Targets tidal volume of 6mL/kg predicted body weight, plateau pressure ≤30 cmH2O, SpO2 88-95%, and pH 7.3-7.45
    • Decrease tidal volume from 8mL/kg to 6mL/kg predicted body weight over 4 hours, then continue to decrease in 1mL/kg increments until plateau pressures <30 or tidal volume 4mL/kg
    • PEEP over 15 cmH2O may be protective in severe ARDS
    • Permissive hypercapnia to CO2 60-70 and pH 7.2-7.25, if needed
  • Prone positioning
  • Maintain euvolemia